AI guides trauma surgeons in real time

A developer of software used in orthopedic surgery has demonstrated the utility of AI-aided fluoroscopy guidance for operating on orthopedic trauma patients.

Salt Lake City-based OrthoGrid Systems announced the successful testing of its product by surgeons at University Medical Center (UMC) in Las Vegas.

The company says its R&D personnel worked with its research and education team in France to imbue a neural network with the ability to identify and track orthopedic implants, instruments and surgical tools.

UMC orthopedic surgeon Jessica Bear, MD, says equipping orthopedic trauma specialists with a way to visualize the trajectories of these items live during surgery “offers the hope of improved efficiency, accuracy and reproducibility.”

The company adds that the UMC demonstration paves the way for its technology to “solve many more intraoperative challenges that are currently unassisted or unsupported digitally.”

Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.